PharmiWeb.com - Global Pharma News & Resources

Healthcare - Press Releases

Date Title Company
14-Mar-2024 FemTech and Women’s Health start-ups urged to join Discovery Park’s growth programme, offering a support package worth over £50K Discovery Spark
14-Mar-2024 New Phase 2b results for amlitelimab support potential for best-in-class maintenance of response in atopic dermatitis Sanofi
13-Mar-2024 The UK National Institute for Health and Care Excellence issues Final Guidance TA 953 recommending fluocinolone acetonide intravitreal implant for the treatment of visual impairment caused by chronic diabetic macular oedema, irrespective of the type of lens Alimera Sciences, Inc.
12-Mar-2024 PATIENTS IN SCOTLAND WITH AN ADVANCED FORM OF PROSTATE CANCER CAN NOW ACCESS LYNPARZA (OLAPARIB) WITH ABIRATERONE AND PREDNISONE OR PREDNISOLONE WITHOUT A BIOMARKER TEST AstraZeneca and MSD
12-Mar-2024 New Report Reveals Top Life Sciences Marketing Trends Over the Past Year SCORR Marketing 
12-Mar-2024 medac unveils new Global Corporate Brand medac group
12-Mar-2024 Alcidion and Novari Health Forge Strategic Partnership to Advance Patient Flow Management Alcidion Group Limited
12-Mar-2024 Clinigen boosts senior team with three strategic hires Clinigen
12-Mar-2024 METAFORA BIOSYSTEMS SECURES REIMBURSEMENT IN FRANCE FOR FIRST IVD TO HELP DIAGNOSE GLUT1 DEFICIENCY SYNDROME Metafora Biosystems
11-Mar-2024 OncoZenge Explores Strategic Options for BupiZenge™ in China OncoZenge
11-Mar-2024 Aptamer Group progresses partnership with Unilever plc Aptamer Group
08-Mar-2024 Johnson & Johnson submits application to the European Medicines Agency for DARZALEX® (daratumumab)-based quadruplet therapy for the treatment of patients with transplant-eligible, newly diagnosed multiple myeloma Johnson & Johnson
08-Mar-2024 Johnson & Johnson submits application to the European Medicines Agency for DARZALEX® (daratumumab)-based quadruplet therapy for the treatment of patients with transplant-eligible, newly diagnosed multiple myeloma Johnson & Johnson
08-Mar-2024 Roche presents positive topline CGM accuracy data at the 17th International Conference on Advanced Technologies and Treatments for Diabetes Roche
08-Mar-2024 MitoRx Therapeutics Strengthens Scientific Advisory Board with Appointment of Four International Experts MitoRx Therapeutics
08-Mar-2024 ramarketing announces strategic leadership appointments to support global growth ramarketing
08-Mar-2024 WELLCOME APPOINTS MHP GROUP MHP Group Limited
08-Mar-2024 Curium Announces First Commercial Doses in Italy of PYLCLARI® – An Innovative 18F-PSMA PET Tracer Indicated in Patients With Prostate Cancer Curium
08-Mar-2024 Accumulus Synergy Adds Two World-Class Executives to Its Leadership Team Accumulus Synergy, Inc.
08-Mar-2024 US FDA grants Orphan Drug Designation for iOnctura’s first-in-class autotaxin cancer therapy iOnctura